Fingerprint
Dive into the research topics of 'Phase 1 study of ARQ 761, a β-lapachone analogue that promotes NQO1-mediated programmed cancer cell necrosis'. Together they form a unique fingerprint.- Sort by
- Weight
- Alphabetically
Phase 1 study of ARQ 761, a β-lapachone analogue that promotes NQO1-mediated programmed cancer cell necrosis
David E. Gerber, M. Shaalan Beg, Farjana Fattah, Arthur E. Frankel, Oluwatomilade Fatunde, Yull Arriaga, Jonathan E. Dowell, Ajit Bisen, Richard D. Leff, Claudia C. Meek, William C. Putnam, Raja Reddy Kallem, Indhumathy Subramaniyan, Ying Dong, Joyce Bolluyt, Venetia Sarode, Xin Luo, Yang Xie, Brian Schwartz, David A. Boothman
Research output: Contribution to journal › Article › peer-review
57
Scopus
citations